You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice
|
---|---|
Published in |
BMC Cancer, September 2014
|
DOI | 10.1186/1471-2407-14-674 |
Pubmed ID | |
Authors |
Mark Linch, Spyridon Gennatas, Stanislav Kazikin, Jhangir Iqbal, Ranga Gunapala, Kathryn Priest, Joanne Severn, Alison Norton, Bee Ayite, Jaishree Bhosle, Mary O’Brien, Sanjay Popat |
Abstract |
Malignant mesothelioma (MM) carries a poor prognosis and response rates to palliative chemotherapy remain low. Identifying patients with MM that are unlikely to respond to chemotherapy could prevent futile treatments and improve patient quality of life. Studies have suggested that soluble mesothelin is a potential biomarker for early diagnosis and prognosis of MM. We set out to explore the utility of serum mesothelin in routine clinical practice. |
Mendeley readers
The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 24 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 7 | 29% |
Student > Postgraduate | 3 | 13% |
Researcher | 3 | 13% |
Other | 2 | 8% |
Student > Bachelor | 2 | 8% |
Other | 3 | 13% |
Unknown | 4 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 11 | 46% |
Biochemistry, Genetics and Molecular Biology | 2 | 8% |
Environmental Science | 1 | 4% |
Business, Management and Accounting | 1 | 4% |
Veterinary Science and Veterinary Medicine | 1 | 4% |
Other | 4 | 17% |
Unknown | 4 | 17% |